Follow
Xiaowei Xu, MD, PhD
Xiaowei Xu, MD, PhD
Professor at University of Pennsylvania, Departments of Pathology and Laboratory Medicine and
Verified email at pennmedicine.upenn.edu - Homepage
Title
Cited by
Cited by
Year
Lever's histopathology of the skin
R Elenitsas, GF Murphy, BL Johnson, X Xu
Wolters Kluwer, 2009
2193*2009
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
TS Victor, AJ Rech, A Maity, R Rengan, KE Pauken, E Stelekati, JL Benci, ...
Nature 520 (7547), 373-377, 2015
19202015
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
G Bollag, P Hirth, J Tsai, J Zhang, PN Ibrahim, H Cho, W Spevak, C Zhang, ...
Nature 467 (7315), 596-599, 2010
18282010
A tumorigenic subpopulation with stem cell properties in melanomas
D Fang, TK Nguyen, K Leishear, R Finko, AN Kulp, S Hotz, PA Van Belle, ...
Cancer research 65 (20), 9328-9337, 2005
15862005
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
G Chen, AC Huang, W Zhang, G Zhang, M Wu, W Xu, Z Yu, J Yang, ...
Nature 560 (7718), 382-386, 2018
13902018
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
J Villanueva, A Vultur, JT Lee, R Somasundaram, M Fukunaga-Kalabis, ...
Cancer cell 18 (6), 683-695, 2010
13832010
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ...
Nature 545 (7652), 60-65, 2017
11392017
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification
J Guo, L Si, Y Kong, KT Flaherty, X Xu, Y Zhu, CL Corless, L Li, H Li, ...
Journal of clinical oncology 29 (21), 2904-2909, 2011
7862011
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
O Khan, JR Giles, S McDonald, S Manne, SF Ngiow, KP Patel, MT Werner, ...
Nature 571 (7764), 211-218, 2019
6672019
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
T Condamine, GA Dominguez, JI Youn, AV Kossenkov, S Mony, ...
Science immunology 1 (2), aaf8943-aaf8943, 2016
5022016
Isolation of a novel population of multipotent adult stem cells from human hair follicles
H Yu, D Fang, SM Kumar, L Li, TK Nguyen, G Acs, M Herlyn, X Xu
The American journal of pathology 168 (6), 1879-1888, 2006
4232006
Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
XH Ma, SF Piao, S Dey, Q Mcafee, G Karakousis, J Villanueva, LS Hart, ...
The Journal of clinical investigation 124 (3), 1406-1417, 2014
3922014
Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors
V Kumar, L Donthireddy, D Marvel, T Condamine, F Wang, ...
Cancer cell 32 (5), 654-668. e5, 2017
3902017
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ...
Nature medicine 25 (3), 454-461, 2019
3712019
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
SM Kumar, S Liu, H Lu, H Zhang, PJ Zhang, PA Gimotty, M Guerra, W Guo, ...
Oncogene 31 (47), 4898-4911, 2012
3372012
Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy
Y Zhang, R Kurupati, L Liu, XY Zhou, G Zhang, A Hudaihed, F Filisio, ...
Cancer cell 32 (3), 377-391. e9, 2017
3122017
CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation
V Kumar, P Cheng, T Condamine, S Mony, LR Languino, JC McCaffrey, ...
Immunity 44 (2), 303-315, 2016
2972016
Benign pigmented lesions and malignant melanoma
D Elder, R Elenitsas, GF Murphy, X Xu
Lever's histopathology of the skin 9, 742-73, 1997
2951997
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system
A Jambusaria-Pahlajani, PA Kanetsky, PS Karia, WT Hwang, JM Gelfand, ...
JAMA dermatology 149 (4), 402-410, 2013
2782013
Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms
JC Beltra, S Manne, MS Abdel-Hakeem, M Kurachi, JR Giles, Z Chen, ...
Immunity 52 (5), 825-841. e8, 2020
2772020
The system can't perform the operation now. Try again later.
Articles 1–20